Keywords
How to Cite
Abstract
Tulyaremiya (tularemia) — Francisella tularensis bakteriyasi qo‘zg‘atuvchi zoonoz tabiatdagi o‘ta xavfli infeksiya bo‘lib, odam va hayvonlarda turli klinik shakllarda (yara-limfadenit, o‘pka, tifoid, okuloglandulyar va boshqalar) kechadi. Kasallikning past infeksion dozasi (10 CFU), aerozol orqali tarqalishi va bioterrorizm vositasi sifatida potensiali tufayli laboratoriya diagnostikasi alohida ahamiyatga ega. Ushbu maqolada F. tularensis ning laboratoriya diagnostikasi zamonaviy usullari, ularning afzalliklari, kamchiliklari va amaliy qo‘llanilishi batafsil ko‘rib chiqiladi.
References
1.Nelson C.A., Meaney-Delman D., Fleck-Derderian S. va boshq. Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response — United States, 2025. MMWR Recomm Rep. 2025;74(No. RR-2):1–33.
2.World Health Organization. WHO guidelines on tularaemia. Geneva: WHO; 2007.
3.Maurin M. Tularemia treatment: experimental and clinical data. Front Microbiol. 2024;15:1348323.
4.Plymoth M. va boshq. Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes of Type B Tularemia. Clin Infect Dis. 2024.
5.Hepburn M.J., Simpson D.A. Tularemia: current diagnosis and treatment options. Expert Rev Anti Infect Ther. 2008;6(2):231–240.
6.Celli J. Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harb Perspect Med. 2013;3(4):a010314.
7.Degabriel M. va boshq. Pathogenicity and virulence of Francisella tularensis. Virulence. 2023;14(1):2274638.
8.Dennis D.T. va boshq. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285(21):2763–2773.
9.O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Yuqumli kasalliklarning oldini olish va nazorat qilish bo‘yicha klinik protokollar (zoonoz infeksiyalar bo‘limi). Toshkent, 2020–2023 yillar.
10.Stidham R.A. va boshq. Epidemiological Review of Francisella tularensis: A Case Study in the Complications of Dual Diagnoses. PLoS Curr. 2018.
This work is licensed under a Creative Commons Attribution 4.0 International License.
